Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for Heart and Kidneys in Fabry Disease
NCT05710367Phase 2Unknown
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of dapagliflozin in Fabry disease (FD). Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT05710367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05710367.